What are the most common causes of hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hyponatremia is most commonly caused by excessive water intake relative to sodium levels, with the most frequent causes including medications, syndrome of inappropriate antidiuretic hormone secretion (SIADH), heart failure, liver cirrhosis, and kidney disease. The most frequent causes of hyponatremia include:

  • Medications (particularly thiazide diuretics, SSRIs, and certain antipsychotics)
  • Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • Heart failure
  • Liver cirrhosis
  • Kidney disease Other important causes include:
  • Adrenal insufficiency
  • Hypothyroidism
  • Excessive sweating
  • Vomiting or diarrhea
  • Drinking too much water during endurance exercise Certain conditions like polydipsia (excessive water drinking) can dilute sodium levels, while others like heart failure or cirrhosis cause sodium and water retention with proportionally more water retained, as noted in the 2021 practice guidance by the American Association for the Study of Liver Diseases 1. The body normally maintains sodium balance through complex mechanisms involving the kidneys, adrenal glands, and brain, but when these regulatory systems are disrupted by disease or medications, hyponatremia can develop. Symptoms typically appear when sodium levels fall rapidly or drop below 130 mEq/L and may include headache, confusion, seizures, and in severe cases, coma. Treatment depends on identifying and addressing the underlying cause while carefully correcting sodium levels at an appropriate rate to avoid complications, as recommended in the 2013 ACCF/AHA guideline for the management of heart failure 1.

From the FDA Drug Label

In two double-blind, placebo-controlled, multi-center studies (SALT-1 and SALT-2), a total of 424 patients with euvolemic or hypervolemic hyponatremia (serum sodium <135 mEq/L) resulting from a variety of underlying causes (heart failure, liver cirrhosis, syndrome of inappropriate antidiuretic hormone [SIADH] and others) were treated for 30 days with tolvaptan or placebo, then followed for an additional 7 days after withdrawal.

The most common causes of hyponatremia include:

  • Heart failure
  • Liver cirrhosis
  • Syndrome of inappropriate antidiuretic hormone (SIADH) These conditions were identified as underlying causes of euvolemic or hypervolemic hyponatremia in patients treated with tolvaptan 2.

From the Research

Causes of Hyponatremia

The most common causes of hyponatremia can be categorized based on the volume status of the patient. These include:

  • Hypovolemic hyponatremia, which may be caused by severe burns, gastrointestinal losses, and acute water overload 3
  • Euvolemic hyponatremia, which can be caused by the syndrome of inappropriate antidiuretic hormone (SIADH) secretion, medications, and reset osmostat syndrome 3, 4, 5
  • Hypervolemic hyponatremia, which may be caused by congestive heart failure, liver cirrhosis, and renal disease 3, 6, 7

Specific Causes

Some specific causes of hyponatremia include:

  • Medications, which can cause euvolemic hyponatremia 3, 5
  • SIADH, which is a common cause of euvolemic hyponatremia 3, 4, 5
  • Liver cirrhosis, which can cause hypervolemic hyponatremia 6, 7
  • Congestive heart failure, which can cause hypervolemic hyponatremia 3, 4
  • Renal disease, which can cause hypervolemic hyponatremia 3, 4

Diagnosis and Classification

Diagnosing the underlying cause of hyponatremia is crucial for effective treatment. This can be done by categorizing patients according to their fluid volume status (hypovolemic, euvolemic, or hypervolemic) and measuring plasma osmolality and urinary sodium concentration 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of hyponatremia.

American family physician, 2004

Research

Clinical management of SIADH.

Therapeutic advances in endocrinology and metabolism, 2012

Research

Hyponatremia in Cirrhosis: An Update.

The American journal of gastroenterology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.